Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Identification of a RAS-activating TMEM87A-RASGRF1 Fusion in an Exceptional Responder to Sunitinib with Non-Small Cell Lung Cancer.
Clin Cancer Res. 2020 Aug 1;26(15):4072-4079. doi: 10.1158/1078-0432.CCR-20-0397. Epub 2020 Apr 20.
Clin Cancer Res. 2020.
PMID: 32312893
Free PMC article.
Clinical Trial.
Overcoming MET-Dependent Resistance to Selective RET Inhibition in Patients with RET Fusion-Positive Lung Cancer by Combining Selpercatinib with Crizotinib.
Rosen EY, Johnson ML, Clifford SE, Somwar R, Kherani JF, Son J, Bertram AA, Davare MA, Gladstone E, Ivanova EV, Henry DN, Kelley EM, Lin M, Milan MSD, Nair BC, Olek EA, Scanlon JE, Vojnic M, Ebata K, Hechtman JF, Li BT, Sholl LM, Taylor BS, Ladanyi M, Jänne PA, Rothenberg SM, Drilon A, Oxnard GR.
Rosen EY, et al. Among authors: clifford se.
Clin Cancer Res. 2021 Jan 1;27(1):34-42. doi: 10.1158/1078-0432.CCR-20-2278. Epub 2020 Oct 20.
Clin Cancer Res. 2021.
PMID: 33082208
Free PMC article.
Item in Clipboard
Phase IB Study of Osimertinib in Combination with Navitoclax in EGFR-mutant NSCLC Following Resistance to Initial EGFR Therapy (ETCTN 9903).
Bertino EM, Gentzler RD, Clifford S, Kolesar J, Muzikansky A, Haura EB, Piotrowska Z, Camidge DR, Stinchcombe TE, Hann C, Malhotra J, Villaruz LC, Paweletz CP, Lau CL, Sholl L, Takebe N, Moscow JA, Shapiro GI, Jänne PA, Oxnard GR.
Bertino EM, et al.
Clin Cancer Res. 2021 Mar 15;27(6):1604-1611. doi: 10.1158/1078-0432.CCR-20-4084. Epub 2020 Dec 29.
Clin Cancer Res. 2021.
PMID: 33376097
Free PMC article.
Clinical Trial.
Item in Clipboard
Osimertinib and Selpercatinib Efficacy, Safety, and Resistance in a Multicenter, Prospectively Treated Cohort of EGFR-Mutant and RET Fusion-Positive Lung Cancers.
Rotow J, Patel JD, Hanley MP, Yu H, Awad M, Goldman JW, Nechushtan H, Scheffler M, Kuo CS, Rajappa S, Harada G, Clifford S, Santucci A, Silva L, Tupper R, Oxnard GR, Kherani J, Drilon A.
Rotow J, et al.
Clin Cancer Res. 2023 Aug 15;29(16):2979-2987. doi: 10.1158/1078-0432.CCR-22-2189.
Clin Cancer Res. 2023.
PMID: 36996322
Free PMC article.
Item in Clipboard
Leptomeningeal Response to Capmatinib After Progression on Crizotinib in a Patient With MET Exon 14-Mutant NSCLC.
Cravero P, Vaz N, Ricciuti B, Clifford SE, DiUbaldi G, Drevers D, Morton K, Rivenburgh RE, Nishino M, Awad MM.
Cravero P, et al. Among authors: clifford se.
JTO Clin Res Rep. 2020 Jul 1;1(4):100072. doi: 10.1016/j.jtocrr.2020.100072. eCollection 2020 Nov.
JTO Clin Res Rep. 2020.
PMID: 34589954
Free PMC article.
No abstract available.
Item in Clipboard
The coordination chemistry of tartronic acid with copper: magnetic studies of a quasi-equilateral tricopper triangle.
Pascu G, Deville C, Clifford SE, Guenée L, Besnard C, Krämer KW, Liu SX, Decurtins S, Tuna F, McInnes EJ, Winpenny RE, Williams AF.
Pascu G, et al. Among authors: clifford se.
Dalton Trans. 2014 Jan 14;43(2):656-62. doi: 10.1039/c3dt51838h.
Dalton Trans. 2014.
PMID: 24135913
Item in Clipboard
Cite
Cite